These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 7691700

  • 1. Palliative surgical treatment for recurrent and non-resectable hepatocellular carcinoma.
    Imaoka S, Sasaki Y, Masutani S, Furukawa H, Ishikawa O, Kabuto T, Kameyama M, Koyama H, Iwanaga T.
    Hepatogastroenterology; 1993 Aug; 40(4):342-6. PubMed ID: 7691700
    [Abstract] [Full Text] [Related]

  • 2. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection.
    Eguchi S, Matsumoto S, Hamasaki K, Takatsuki M, Hidaka M, Tajima Y, Sakamoto I, Kanematsu T.
    J Hepatobiliary Pancreat Surg; 2008 Aug; 15(6):627-33. PubMed ID: 18987934
    [Abstract] [Full Text] [Related]

  • 3. The effect of percutaneous ethanol injection therapy on small solitary hepatocellular carcinoma is comparable to that of hepatectomy.
    Kotoh K, Sakai H, Sakamoto S, Nakayama S, Satoh M, Morotomi I, Nawata H.
    Am J Gastroenterol; 1994 Feb; 89(2):194-8. PubMed ID: 8304302
    [Abstract] [Full Text] [Related]

  • 4. Treatment of tumour recurrence after resection of hepatocellular carcinoma. Analysis of 97 consecutive patients.
    Tralhão JG, Dagher I, Lino T, Roudié J, Franco D.
    Eur J Surg Oncol; 2007 Aug; 33(6):746-51. PubMed ID: 17188454
    [Abstract] [Full Text] [Related]

  • 5. [Regional therapy to prevent recurrence after surgery in hepatocellular carcinoma].
    Sasaki Y, Imaoka S, Masutani S, Ohashi I, Iwamoto S, Nakamori S, Ohigashi H, Kameyama M, Hiratsuka M, Ishikawa O.
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1767-70. PubMed ID: 1326927
    [Abstract] [Full Text] [Related]

  • 6. [Treatment of hepatic recurrence after resection of hepatocellular carcinomas].
    Sbaï Idrissi MS, Vons C, Borgonovo G, Mariette D, Smadja C, Franco D.
    Ann Chir; 1998 Aug; 52(6):543-6. PubMed ID: 9752504
    [Abstract] [Full Text] [Related]

  • 7. Repeat hepatic resection for recurrent hepatocellular carcinoma.
    Kakazu T, Makuuchi M, Kawasaki S, Miyagawa S, Hashikura Y, Kosuge T, Takayama T, Yamamoto J.
    Hepatogastroenterology; 1993 Aug; 40(4):337-41. PubMed ID: 8406303
    [Abstract] [Full Text] [Related]

  • 8. Significance of reduction surgery in multidisciplinary treatment of advanced hepatocellular carcinoma with multiple intrahepatic lesions.
    Wakabayashi H, Ushiyama T, Ishimura K, Izuishi K, Karasawa Y, Masaki T, Watanabe S, Kuriyama S, Maeta H.
    J Surg Oncol; 2003 Feb; 82(2):98-103. PubMed ID: 12561065
    [Abstract] [Full Text] [Related]

  • 9. [Influence of different treatment modalities on survival of patients with two -stage resection of unresectable hepatocellular carcinoma].
    Fan J, Wu Z, Tang Z.
    Zhonghua Wai Ke Za Zhi; 2001 Oct; 39(10):745-8. PubMed ID: 16201184
    [Abstract] [Full Text] [Related]

  • 10. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.
    Covey AM, Maluccio MA, Schubert J, BenPorat L, Brody LA, Sofocleous CT, Getrajdman GI, Fong Y, Brown KT.
    Cancer; 2006 May 15; 106(10):2181-9. PubMed ID: 16596622
    [Abstract] [Full Text] [Related]

  • 11. [Surgery-predominant comprehensive therapy for 134 patients with small hepatocellular carcinoma].
    Mo QG, Liang AM, Yang NW, Zhao YN, Yuan WP.
    Ai Zheng; 2003 Feb 15; 22(2):189-91. PubMed ID: 12600298
    [Abstract] [Full Text] [Related]

  • 12. Surgical treatment of recurrent hepatocellular carcinoma.
    Zhou XD, Yu YQ, Tang ZY, Yang BH, Lu JZ, Lin ZY, Ma ZC, Xu DB, Zhang BH, Zheng YX.
    Hepatogastroenterology; 1993 Aug 15; 40(4):333-6. PubMed ID: 8406302
    [Abstract] [Full Text] [Related]

  • 13. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS, Lim YS, Lee HC, Suh DJ, Lee YJ, Lee SG.
    Aliment Pharmacol Ther; 2008 Feb 15; 27(4):338-45. PubMed ID: 18047564
    [Abstract] [Full Text] [Related]

  • 14. Treatment of solitary small hepatocellular carcinoma: consideration of hepatic functional reserve and mode of recurrence.
    Horigome H, Nomura T, Nakao H, Saso K, Takahashi Y, Akita S, Sobue S, Mizuno Y, Nojiri S, Hirose A, Masuko K, Murasaki G, Fujino N, Nakahara R, Ichikawa T, Itoh M.
    Hepatogastroenterology; 2000 Feb 15; 47(32):507-11. PubMed ID: 10791223
    [Abstract] [Full Text] [Related]

  • 15. [Appraisal of postoperative transcatheter arterial chemoembolization (TACE) for prevention and treatment of hepatocellular carcinoma recurrence].
    Lin Z, Ren Z, Xia J.
    Zhonghua Zhong Liu Za Zhi; 2000 Jul 15; 22(4):315-7. PubMed ID: 11778559
    [Abstract] [Full Text] [Related]

  • 16. The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma.
    Zhang Z, Liu Q, He J, Yang J, Yang G, Wu M.
    Cancer; 2000 Dec 15; 89(12):2606-12. PubMed ID: 11135222
    [Abstract] [Full Text] [Related]

  • 17. Aggressive multimodality treatment for intra-hepatic recurrence of hepatocellular carcinoma following hepatic resection.
    Chan KM, Lee WC, Hung CF, Yu MC, Jan YY, Chen MF.
    Chang Gung Med J; 2005 Aug 15; 28(8):543-50. PubMed ID: 16265844
    [Abstract] [Full Text] [Related]

  • 18. [Diagnosis and treatment for recurrent hepatocellular carcinoma].
    Yoshikawa M, Ebara M, Fukuda H, Sugiura N, Saisho H.
    Gan To Kagaku Ryoho; 1998 Feb 15; 25(3):327-32. PubMed ID: 9492824
    [Abstract] [Full Text] [Related]

  • 19. [Efficacy of transarterial embolization combined with percutaneous ethanol injection therapy for recurrent hepatocellular carcinoma].
    Shimamura T, Une Y, Nakajima Y, Sato N, Matsushita M, Kamiyama T, Uchino J.
    Gan To Kagaku Ryoho; 1994 Sep 15; 21(13):2229-32. PubMed ID: 7944447
    [Abstract] [Full Text] [Related]

  • 20. [Long-term results of interventional treatment of large unresectable hepatocellular carcinoma (HCC): significant survival benefit from combined transcatheter arterial chemoembolization (TACE) and percutaneous ethanol injection (PEI) compared to TACE monotherapy].
    Lubienski A, Bitsch RG, Schemmer P, Grenacher L, Düx M, Kauffmann GW.
    Rofo; 2004 Dec 15; 176(12):1794-802. PubMed ID: 15573291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.